Literature DB >> 10493584

Early events in the disulfide-coupled folding of BPTI.

G Bulaj1, D P Goldenberg.   

Abstract

Recent studies of the refolding of reduced bovine pancreatic trypsin inhibitor (BPTI) have shown that a previously unidentified intermediate with a single disulfide is formed much more rapidly than any other one-disulfide species. This intermediate contains a disulfide that is present in the native protein (between Cys14 and 38), but it is thermodynamically less stable than the other two intermediates with single native disulfides. To characterize the role of the [14-38] intermediate and the factors that favor its formation, detailed kinetic and mutational analyses of the early disulfide-formation steps were carried out. The results of these studies indicate that the formation of [14-38] from the fully reduced protein is favored by both local electrostatic effects, which enhance the reactivities of the Cys14 and 38 thiols, and conformational tendencies that are diminished by the addition of urea and are enhanced at lower temperatures. At 25 degrees C and pH 7.3, approximately 35% of the reduced molecules were found to initially form the 14-38 disulfide, but the majority of these molecules then undergo intramolecular rearrangements to generate non-native disulfides, and subsequently the more stable intermediates with native disulfides. Amino acid replacements, other than those involving Cys residues, were generally found to have only small effects on either the rate of forming [14-38] or its thermodynamic stability, even though many of the same substitutions greatly destabilized the native protein and other disulfide-bonded intermediates. In addition, those replacements that did decrease the steady-state concentration of [14-38] did not adversely affect further folding and disulfide formation. These results suggest that the weak and transient interactions that are often detected in unfolded proteins and early folding intermediates may, in some cases, not persist or promote subsequent folding steps.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493584      PMCID: PMC2144392          DOI: 10.1110/ps.8.9.1825

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  59 in total

1.  Computer simulation of protein folding.

Authors:  M Levitt; A Warshel
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

2.  Electrophoretic analysis of the unfolding of proteins by urea.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1979-04-05       Impact factor: 5.469

3.  Reactivities of the cysteine residues of the reduced pancreatic trypsin inhibitor.

Authors:  T Creighton
Journal:  J Mol Biol       Date:  1975-08-25       Impact factor: 5.469

4.  Effects of urea and guanidine-HCl on the folding and unfolding of pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1977-06-25       Impact factor: 5.469

5.  Energetics of folding and unfolding of pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1977-06-25       Impact factor: 5.469

6.  Interactions between cysteine residues as probes of protein conformation: the disulphide bond between Cys-14 and Cys-38 of the pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1975-08-25       Impact factor: 5.469

Review 7.  Experimental studies of protein folding and unfolding.

Authors:  T E Creighton
Journal:  Prog Biophys Mol Biol       Date:  1978       Impact factor: 3.667

8.  [Preparation and properties of active derivatives of the trypsin-kallikrein inhibitor from bovine organs].

Authors:  H Fritz; H Schult; R Meister; E Werle
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-12

9.  The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1974-08-15       Impact factor: 5.469

10.  The use of maleic anhydride for the reversible blocking of amino groups in polypeptide chains.

Authors:  P J Butler; J I Harris; B S Hartley; R Lebeman
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857

View more
  8 in total

1.  Three amino acids that are critical to formation and stability of the P22 tailspike trimer.

Authors:  Matthew J Gage; Jennifer L Zak; Anne Skaja Robinson
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

2.  Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor.

Authors:  Elena Zakharova; Martin P Horvath; David P Goldenberg
Journal:  J Mol Biol       Date:  2008-07-30       Impact factor: 5.469

3.  Protein folding guides disulfide bond formation.

Authors:  Meng Qin; Wei Wang; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-21       Impact factor: 11.205

4.  Genetic selection for enhanced folding in vivo targets the Cys14-Cys38 disulfide bond in bovine pancreatic trypsin inhibitor.

Authors:  Linda Foit; Antje Mueller-Schickert; Bharath S Mamathambika; Stefan Gleiter; Caitlyn L Klaska; Guoping Ren; James C A Bardwell
Journal:  Antioxid Redox Signal       Date:  2011-01-23       Impact factor: 8.401

5.  Alteration of the disulfide-coupled folding pathway of BPTI by circular permutation.

Authors:  Grzegorz Bulaj; Rachel E Koehn; David P Goldenberg
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

6.  Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.

Authors:  John D Hulleman; Shalesh Kaushal; William E Balch; Jeffery W Kelly
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

7.  Harnessing selenocysteine reactivity for oxidative protein folding.

Authors:  Norman Metanis; Donald Hilvert
Journal:  Chem Sci       Date:  2014-09-23       Impact factor: 9.825

Review 8.  Revisiting the Formation of a Native Disulfide Bond: Consequences for Protein Regeneration and Beyond.

Authors:  Mahesh Narayan
Journal:  Molecules       Date:  2020-11-16       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.